Medicine
Vabysmo 6 mg/0.05 mL injection
Vabysmo 6 mg/0.05 mL injection is a prescription medicine containing Faricimab for intravitreal use, marketed by Genentech, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store VABYSMO in the refrigerator between 2°C to 8°C (36°F to 46°F). Do not…
Key facts
- Active ingredient (INN)
- Faricimab
- Brand
- Vabysmo
- Strength
- 6 mg/0.05 mL
- Dosage form
- Injection
- Route
- Intravitreal
- Packs
- 1 vial of 0.05 mL, 1 syringe of 0.05 mL
- Marketing authorisation holder
- Genentech
- Manufacturer
- Genentech
- Origin register
- US FDA, United States
- Storage
- Store VABYSMO in the refrigerator between 2°C to 8°C (36°F to 46°F). Do not freeze. Prior to use, the unopened prefilled syringe or glass vial of VABYSMO may be kept at room temperature, 20°C to 25°C (68°F to 77°F), for up to 24 hours. Do not shake. Keep the sealed tray containing the prefilled syringe or the vial in the original carton to protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01L Eye medicines, subgroup S01L
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 January 2022
- Identifiers
- RxCUI 2591588, 2591594, 2692684 +1DailyMed set ID 04cc9ef7-c02a-4e92-a655-0062674e8487NDC 50242-096Application BLA761235
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Faricimab is a prescription medicine indicated for the treatment of patients with vABYSMO is a vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2) inhibitor indicated for the treatment of patients with, among other approved uses. MedsAcross supplies Faricimab for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FaricimabFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VABYSMO prescribing information (Genentech) · U.S. National Library of Medicine, DailyMed
- Vabysmo: European public assessment report (EPAR) · European Medicines Agency
Need Vabysmo 6 mg/0.05 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.